MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Africa

Overview

Journal J Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2019 Nov 1

PMID 31671453

Citations 22

Authors

Jaymin C Patel

Heidi M Soeters

Alpha Oumar Diallo

Brice W Bicaba

Goumbi Kadade

Assetou Y Dembele

Mahamat A Acyl

Christelle Nikiema

Clement Lingani

Cynthia Hatcher

Anna M Acosta

Jennifer D Thomas

Fabien Diomande

Stacey Martin

Thomas A Clark

Richard Mihigo

Rana A Hajjeh

Catherine H Zilber

Flavien Ake

Sarah A Mbaeyi

Xin Wang

Jennifer C Moisi

Olivier Ronveaux

Jason M Mwenda

Ryan T Novak

Affiliations

Soon will be listed here.

Abstract

Meningococcal meningitis remains a significant public health threat, especially in the African meningitis belt where Neisseria meningitidis serogroup A historically caused large-scale epidemics. With the rollout of a novel meningococcal serogroup A conjugate vaccine (MACV) in the belt, the World Health Organization recommended case-based meningitis surveillance to monitor MACV impact and meningitis epidemiology. In 2014, the MenAfriNet consortium was established to support strategic implementation of case-based meningitis surveillance in 5 key countries: Burkina Faso, Chad, Mali, Niger, and Togo. MenAfriNet aimed to develop a high-quality surveillance network using standardized laboratory and data collection protocols, develop sustainable systems for data management and analysis to monitor MACV impact, and leverage the surveillance platform to perform special studies. We describe the MenAfriNet consortium, its history, strategy, implementation, accomplishments, and challenges.

Citing Articles

Spatiotemporal dynamics of the oropharyngeal microbiome in a cohort of Ivorian school children.

Diallo K, Missa K, Tuo K, Tiemele L, Ouattara A, Gboko K Sci Rep. 2024; 14(1):30895.

PMID: 39730689 PMC: 11681117. DOI: 10.1038/s41598-024-81829-6.

Square the Circle: Diversity of Viral Pathogens Causing Neuro-Infectious Diseases.

Nurmukanova V, Matsvay A, Gordukova M, Shipulin G Viruses. 2024; 16(5).

PMID: 38793668 PMC: 11126052. DOI: 10.3390/v16050787.

Expansion of Neisseria meningitidis Serogroup C Clonal Complex 10217 during Meningitis Outbreak, Burkina Faso, 2019.

Kekeisen-Chen J, Tarbangdo F, Sharma S, Marasini D, Marjuki H, Kibler J Emerg Infect Dis. 2024; 30(3):460-468.

PMID: 38407254 PMC: 10902552. DOI: 10.3201/eid3003.221760.

Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet Neurol. 2023; 22(8):685-711.

PMID: 37479374 PMC: 10356620. DOI: 10.1016/S1474-4422(23)00195-3.

Association between Meningococcal Meningitis and Santa Ana Winds in Children and Adolescents from Tijuana, Mexico: A Need for Vaccination.

Chacon-Cruz E, Lopatynsky-Reyes E Trop Med Infect Dis. 2023; 8(3).

PMID: 36977137 PMC: 10055931. DOI: 10.3390/tropicalmed8030136.

References

Mbaeyi S, Lingani C, Diallo A, Bicaba B, Ouedraogo-Traore R, Acyl M . Improving Case-Based Meningitis Surveillance in 5 Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017. J Infect Dis. 2019; 220(220 Suppl 4):S155-S164. DOI: 10.1093/infdis/jiz303. View

Patel J, George J, Vuong J, Potts C, Bozio C, Clark T . Rapid Laboratory Identification of Neisseria meningitidis Serogroup C as the Cause of an Outbreak - Liberia, 2017. MMWR Morb Mortal Wkly Rep. 2017; 66(42):1144-1147. PMC: 5689101. DOI: 10.15585/mmwr.mm6642a5. View

Bell B, Damon I, Jernigan D, Kenyon T, Nichol S, OConnor J . Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014-2016 Ebola Epidemic. MMWR Suppl. 2016; 65(3):4-11. DOI: 10.15585/mmwr.su6503a2. View

Feagins A, Vuong J, Fernandez K, Njanpop-Lafourcade B, Mwenda J, Sanogo Y . The Strengthening of Laboratory Systems in the Meningitis Belt to Improve Meningitis Surveillance, 2008-2018: A Partners' Perspective. J Infect Dis. 2019; 220(220 Suppl 4):S175-S181. DOI: 10.1093/infdis/jiz337. View

LaForce F, Djingarey M, Viviani S, Preziosi M . Lessons from the Meningitis Vaccine Project. Viral Immunol. 2017; 31(2):109-113. DOI: 10.1089/vim.2017.0120. View

Mounkoro D, Nikiema C, Maman I, Sakande S, Bozio C, Tall H . Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016. J Infect Dis. 2019; 220(220 Suppl 4):S216-S224. PMC: 6822970. DOI: 10.1093/infdis/jiz330. View

Kristiansen P, Diomande F, Ky Ba A, Sanou I, Ouedraogo A, Ouedraogo R . Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis. 2012; 56(3):354-63. DOI: 10.1093/cid/cis892. View

Greenwood B . Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 2000; 93(4):341-53. DOI: 10.1016/s0035-9203(99)90106-2. View

Zoma R, Walldorf J, Tarbangdo F, Patel J, Diallo A, Nkwenkeu S . Evaluation of the Impact of Meningococcal Serogroup A Conjugate Vaccine Introduction on Second-Year-of-Life Vaccination Coverage in Burkina Faso. J Infect Dis. 2019; 220(220 Suppl 4):S233-S243. PMC: 10718265. DOI: 10.1093/infdis/jiz304. View

10.

. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali. MMWR Morb Mortal Wkly Rep. 2012; 61(50):1025-8. View

11.

Kambire D, Soeters H, Ouedraogo-Traore R, Medah I, Sangare L, Yameogo I . Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013. PLoS One. 2016; 11(11):e0166384. PMC: 5104358. DOI: 10.1371/journal.pone.0166384. View

12.

Novak R, Ronveaux O, Bita A, Ake H, Lessa F, Wang X . Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa. J Infect Dis. 2019; 220(220 Suppl 4):S279-S285. PMC: 6822967. DOI: 10.1093/infdis/jiz421. View

13.

Novak R, Kambou J, Diomande F, Tarbangdo T, Ouedraogo-Traore R, Sangare L . Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis. 2012; 12(10):757-64. PMC: 4831863. DOI: 10.1016/S1473-3099(12)70168-8. View

14.

Frasch C, Preziosi M, LaForce F . Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM). Hum Vaccin Immunother. 2012; 8(6):715-24. DOI: 10.4161/hv.19619. View

15.

Kambire D, Soeters H, Ouedraogo-Traore R, Medah I, Sangare L, Yameogo I . Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015. J Infect. 2017; 76(3):270-279. PMC: 5821694. DOI: 10.1016/j.jinf.2017.12.002. View

16.

Greenwood B, Stuart J . A vaccine to prevent epidemic meningitis in Africa. Lancet Infect Dis. 2012; 12(10):738-9. DOI: 10.1016/S1473-3099(12)70182-2. View

17.

Sidikou F, Zaneidou M, Alkassoum I, Schwartz S, Issaka B, Obama R . Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data. Lancet Infect Dis. 2016; 16(11):1288-1294. PMC: 5737706. DOI: 10.1016/S1473-3099(16)30253-5. View

18.

Diallo A, Kiemtore T, Bicaba B, Medah I, Tarbangdo T, Sanou S . Development and Implementation of a Cloud-Based Meningitis Surveillance and Specimen Tracking System in Burkina Faso, 2018. J Infect Dis. 2019; 220(220 Suppl 4):S198-S205. PMC: 6822968. DOI: 10.1093/infdis/jiz376. View

19.

Trotter C, Lingani C, Fernandez K, Cooper L, Bita A, Tevi-Benissan C . Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data. Lancet Infect Dis. 2017; 17(8):867-872. DOI: 10.1016/S1473-3099(17)30301-8. View

20.

Soeters H, Diallo A, Bicaba B, Kadade G, Dembele A, Acyl M . Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017. J Infect Dis. 2019; 220(220 Suppl 4):S165-S174. PMC: 6853282. DOI: 10.1093/infdis/jiz358. View